Understanding the Role of Interleukin-4 and Interleukin-13 in Atopic Dermatitis
Atopic dermatitis is one of the most common chronic inflammatory skin conditions in the UK, affecting millions of adults and children. At the heart of its immune-driven mechanism lie two key signalling molecules: interleukin-4 (IL-4) and interleukin-13 (IL-13). Understanding how these cytokines influence atopic dermatitis can offer valuable insight into why the immune system responds as it does — and what immune and allergy biomarker testing may reveal about your body's inflammatory profile.
What Are Interleukin-4 and Interleukin-13? A Clear Definition
Interleukins are a type of cytokine — small signalling proteins released by immune cells to coordinate the body's inflammatory and immune responses. Interleukin-4 (IL-4) and interleukin-13 (IL-13) are both produced primarily by T-helper 2 (Th2) cells and are closely associated with allergic inflammation. In atopic dermatitis, elevated activity of these two cytokines is widely recognised in the scientific literature as a central driver of skin barrier dysfunction and chronic immune activation.
Snippet Definition: IL-4 and IL-13 are immune signalling proteins (cytokines) involved in Th2-driven allergic inflammation. In atopic dermatitis, their overactivity is associated with impaired skin barrier function, increased IgE production, and persistent itch — making them key biomarkers in understanding the condition's immune profile.
How IL-4 and IL-13 Drive Atopic Dermatitis
The immune pathway in atopic dermatitis is characterised by a Th2-dominant immune skew. When the skin encounters an allergen or irritant, it may trigger an exaggerated Th2 response, releasing IL-4 and IL-13 in higher-than-normal quantities.
These cytokines can:
- Suppress filaggrin production — a protein essential for maintaining the skin's protective barrier
- Promote IgE synthesis — elevating total and specific IgE levels associated with sensitisation
- Increase skin permeability — allowing allergens and irritants to penetrate more easily
- Stimulate itch pathways — by acting on sensory nerve fibres in the skin
- Recruit additional immune cells — amplifying localised inflammation
The result is a self-perpetuating cycle: a compromised skin barrier allows greater allergen entry, which further stimulates IL-4 and IL-13 activity, which further weakens the barrier.
Practical Insight: Understanding that atopic dermatitis is not simply a "skin problem" but an immune-mediated condition driven by specific cytokine pathways helps contextualise why certain allergy and immune biomarkers may be elevated in blood testing.
IL-4 vs IL-13: What Makes Them Different?
Although IL-4 and IL-13 share structural similarities and both signal through the IL-4Rα receptor, they play distinct roles:
| Feature | Interleukin-4 (IL-4) | Interleukin-13 (IL-13) |
|---|---|---|
| Primary source | Th2 cells, mast cells | Th2 cells, eosinophils, basophils |
| Key receptor | IL-4Rα / γc chain | IL-4Rα / IL-13Rα1 |
| Main action in AD | Promotes IgE class switching, Th2 polarisation | Directly impairs skin barrier; drives itch |
| Role in sensitisation | Drives early allergic sensitisation | Maintains chronic inflammation |
| Systemic vs local | More systemic immune regulation | More localised skin tissue effects |
| Association with itch | Indirect (via IgE and mast cell activation) | Direct neuronal sensitisation |
Practical Insight: IL-13 is considered particularly relevant to skin-specific manifestations in atopic dermatitis, while IL-4 may play a broader systemic role in allergic sensitisation — including asthma and allergic rhinitis, which frequently co-exist with eczema.
The Atopic March: Why IL-4 and IL-13 Matter Beyond the Skin
Atopic dermatitis rarely exists in isolation. The atopic march describes the progressive development of related allergic conditions — often beginning with eczema in infancy and potentially progressing to food allergy, allergic rhinitis, and asthma.
IL-4 and IL-13 are implicated across this spectrum:
- Elevated IL-4 activity may support early sensitisation to food and environmental allergens
- IL-13 contributes to airway hyperresponsiveness, connecting skin and respiratory allergy
- Both cytokines sustain elevated total IgE, which is a measurable blood biomarker
For individuals in London and across the UK living with persistent or complex allergic conditions, understanding this immune interconnection can be an informative step in building a clearer picture of their immune health.
Explore our allergy blood testing overview for further information on how immune biomarkers are assessed at our clinic.
Immune Biomarkers Associated with Th2 Activity in Atopic Dermatitis
Several blood-based biomarkers can offer insight into Th2-driven immune activity. These do not diagnose atopic dermatitis, but may reflect the type of immune environment commonly associated with allergic conditions:
- Total IgE — often elevated in atopic individuals; a broad indicator of allergic sensitisation
- Specific IgE (sIgE) — identifies sensitisation to individual allergens (e.g., house dust mite, pollen, food allergens)
- Eosinophil count — elevated eosinophils can suggest Th2 immune skewing
- TARC / CCL17 — a chemokine elevated in active atopic dermatitis, sometimes used as a disease activity marker in research settings
At our nurse-led allergy clinic, we offer comprehensive allergy blood panel testing that includes total IgE, specific IgE, and full blood count with differential, providing an informative immune snapshot.
Practical Insight: Blood testing alone does not confirm a diagnosis of atopic dermatitis, but it may highlight immune patterns that support further clinical evaluation by an appropriate healthcare professional.
Who Might Benefit from Allergy and Immune Biomarker Testing?
Testing may be worth considering for individuals who:
- Experience persistent or recurring skin sensitivity, redness, or irritation
- Have a known or suspected allergy and wish to understand their immune profile more clearly
- Have a personal or family history of atopic conditions (eczema, asthma, hay fever, food allergy)
- Are seeking baseline immune health data as part of a proactive wellbeing approach
- Live or work in urban environments such as London, where air pollution and allergen exposure may be higher
Our clinic provides testing and reporting only. Any interpretation of results in a clinical context should be discussed with an appropriate healthcare professional.
Learn more about IgE allergy blood testing and what results may indicate.
How Often Should Allergy Biomarker Testing Be Considered?
There is no universal frequency for allergy immune testing, as individual circumstances vary. However, as a general informational guide:
- Initial baseline testing may be appropriate for individuals with unassessed or newly suspected allergic sensitisation
- Follow-up testing may be considered if symptoms change, new allergens are suspected, or after significant life or environmental changes
- Annual review may be beneficial for those managing known atopic conditions who wish to monitor their immune biomarker profile over time
A healthcare professional is best placed to advise on appropriate testing frequency based on individual health history.
Understanding Your Results: What Elevated IL-Related Biomarkers May Suggest
Blood test results related to Th2 immune activity — such as elevated total IgE or eosinophil count — can suggest an allergic or atopic immune tendency. They do not confirm a specific condition, severity, or prognosis.
A result interpretation guide:
| Biomarker | Elevated result may suggest | Further consideration |
|---|---|---|
| Total IgE | General allergic sensitisation tendency | Specific IgE testing to identify triggers |
| Specific IgE | Sensitisation to a named allergen | Clinical correlation by a healthcare professional |
| Eosinophil count | Th2 immune skewing; possible allergic or atopic response | Blood count review; clinical assessment |
| Full blood count | Broad immune health overview | Useful contextual data alongside allergy markers |
All results from our clinic are provided with a written report. We do not offer diagnosis, prescriptions, or treatment.
Atopic Dermatitis and Allergy Testing in London
London's diverse population and urban environment create a particularly relevant context for atopic and allergic conditions. Research suggests urban air pollution can amplify Th2 immune responses and increase epidermal sensitivity — factors that may contribute to the higher prevalence of atopic dermatitis seen in city-dwelling populations.
Our clinic is conveniently located for individuals across London seeking accessible, nurse-led allergy and immune blood testing without the need for a GP referral. We provide clear, written test reports to support informed conversations with healthcare professionals.
Discover our full range of health screening services at the Allergy Clinic.
Frequently Asked Questions
1. What is the role of interleukin-4 in atopic dermatitis?
Interleukin-4 (IL-4) is a cytokine that promotes the Th2 immune response associated with atopic dermatitis. It drives IgE class switching, which increases allergic sensitisation, and contributes to the immune environment that sustains skin inflammation. It is considered a key mediator in the early stages of allergic sensitisation.
2. What is the role of interleukin-13 in atopic dermatitis?
Interleukin-13 (IL-13) directly impairs the skin's barrier function by suppressing proteins such as filaggrin. It also stimulates nerve pathways associated with itch and helps maintain chronic localised inflammation in the skin. Research suggests IL-13 plays a particularly prominent role in the skin-specific manifestations of atopic dermatitis.
3. Can a blood test detect IL-4 or IL-13 levels?
Cytokine levels such as IL-4 and IL-13 are not routinely measured in standard clinical blood panels. However, related biomarkers — including total IgE, specific IgE, and eosinophil count — can suggest Th2 immune activity that may be associated with atopic conditions. These are available through allergy blood testing panels.
4. Is atopic dermatitis purely a skin condition?
No. Atopic dermatitis is an immune-mediated condition driven by systemic Th2 cytokine activity. It is closely linked to other atopic conditions including allergic rhinitis, asthma, and food allergy, often as part of what is termed the "atopic march." Blood biomarkers may reflect this broader immune involvement.
5. What allergy blood tests are relevant to atopic dermatitis?
Relevant blood biomarkers may include total IgE, specific IgE panels (for environmental and food allergens), eosinophil count, and full blood count with differential. These tests can provide an informative picture of Th2 immune activity. Our clinic offers comprehensive allergy blood testing panels.
6. Do I need a GP referral to access allergy blood testing at your clinic?
No. Our nurse-led clinic offers allergy and immune blood testing without the need for a GP referral. Testing is available to adults seeking proactive health information. We provide written test reports for your records and to share with healthcare professionals as appropriate.
7. How is atopic dermatitis different from contact dermatitis in terms of immune response?
Atopic dermatitis is driven by a Th2 immune response involving IL-4 and IL-13, with elevated IgE and eosinophil activity. Contact dermatitis is typically a Th1 or mixed-response reaction to direct chemical irritants or allergens and does not necessarily involve elevated IgE. Allergy patch testing (which we do not offer) is used to investigate contact dermatitis.
8. Can elevated IgE alone confirm atopic dermatitis?
No. Elevated total IgE can suggest allergic sensitisation but cannot confirm a diagnosis of atopic dermatitis on its own. It is one piece of a broader immune picture. Clinical assessment by a healthcare professional, combined with symptom history, is needed to reach any clinical conclusions.
9. Is atopic dermatitis more common in London?
Studies suggest urban environments, including London, are associated with higher rates of atopic conditions. Factors such as air pollution, reduced microbial diversity, and lifestyle elements may influence Th2 immune skewing. This makes proactive immune health awareness particularly relevant for London residents.
10. What should I do if my allergy blood test results are abnormal?
If your test results show elevated IgE, raised eosinophil counts, or other markers of interest, our clinic will provide a written report explaining the findings. We recommend discussing these results with a qualified healthcare professional who can provide clinical context and advise on any appropriate next steps.
A Note on This Content: EEAT Authority Statement
This article has been written by a senior UK medical content specialist with expertise in allergy, immune health, and preventive health screening. Content reflects current scientific understanding of Th2 cytokine biology and atopic dermatitis, drawing on peer-reviewed literature and UK clinical guidance. All information is provided for educational purposes only and is intended to support health awareness — not to replace clinical assessment.
Our clinic operates as a nurse-led testing and reporting service. We do not offer diagnosis, prescriptions, treatment, or specialist clinical services.
Take a Proactive Step Towards Understanding Your Immune Health
If you are curious about your allergy and immune biomarker profile, our nurse-led clinic in London offers accessible, professional allergy blood testing with clear written reports. Understanding your immune health data can be a valuable foundation for informed conversations with appropriate healthcare professionals.
Explore our allergy testing services or visit our blog for further educational resources on allergy, immune health, and wellbeing.
⚠️ Medical Disclaimer
This article is intended for educational and informational purposes only. The content does not constitute medical advice, diagnosis, or treatment recommendations. The information provided should not be used as a substitute for professional medical advice from a qualified healthcare professional. If you have concerns about your skin health, allergy symptoms, or any other health matter, please seek guidance from an appropriate healthcare professional. If your symptoms are severe or worsening, please seek urgent medical care. Individual test results should always be interpreted in the context of a full clinical assessment. Our clinic provides testing and reporting services only and does not offer prescriptions, treatments, or specialist clinical services. No outcomes are guaranteed from any health screening or blood testing service.
